India NCLT Insolvency Resolution Filings — June 26, 2026

Resolution plan approved at ₹5.55 crore by CoC with 98.55% voting share present, signaling creditor confidence in M/s Barouliya Fragrancia & co-sponsors despite withdrawals

Two resolution applicants withdrew (MG369 Finventure & Prafull Chedda Enterprise), indicating possible disagreement over valuation or process—creates uncertainty around plan feasibility

Preponement of CoC meeting at creditor request shows active creditor engagement, a positive for resolution momentum

NCLT-directed shareholder meeting on July 27, 2026 provides a clear near-term catalyst for restructuring decision [NEUTRAL-to-BULLISH]

Allegation by Prafull Chedda that CIR process violated IBC rules, though CoC supported RP—elevates legal/regulatory risk for the resolution plan

Zero period-over-period financial data or forward guidance—signals early-stage insolvency with no revenue/margin insights, limiting comparability

Pending legal application for extension of CIRP period delays resolution timeline, increasing cost and uncertainty for stakeholders

High quorum (98.55%) suggests strong creditor alignment—supports plan execution if legal hurdles cleared

Allegation that CIRP violated IBC rules, though CoC members overturned it—raises risk of litigation or NCLT intervention, potentially nullifying the approved plan

Two applicants withdrew plans, indicating either low confidence in the asset value or process—reduces competitive tension and may signal overvaluation of the approved plan

Pending legal application to extend the CIRP period—extends uncertainty, delays creditor recovery, and increases professional fees (RP costs)

Complete absence of financial data in the filing—makes it impossible to assess the company’s viability or the rationale behind the shareholder meeting

Only a shareholder meeting notice with no resolution plan or details—indicates the company is still in early IBC stages with no clear path to resolution [LOW-to-MEDIUM RISK]

Resolution applicant (Barouliya Fragrancia & individuals) may lack sufficient track record—no prior comparable deals disclosed in the filing

Preponement of meeting caused by creditor request hints at coordination challenges among stakeholders

No insider transactions filed—no signal of management or promoter conviction, typical for companies under CIRP where management is replaced

Approved plan at ₹5.55 crore provides a floor value; if CIRP extension is granted and legal challenges resolved, early investors in distressed debt could see recovery upside

If shareholders vote in favor of restructuring or further funding, the company may avoid liquidation—event-driven play with July 27 deadline

In the event of plan failure, creditors may be forced to accept lower haircuts—new bidders could step in with a lower base for negotiation

If the IBC process gains speed (NBFC sector recovery theme), the same asset could be revalued higher—monitor macro liquidity changes

NCLT convening a shareholder meeting suggests potential for a revival scheme (slump sale, capital infusion)—speculative retail/event-driven play

Both stocks likely trade at deep discounts due to CIRP status—any positive NCLT order could trigger rapid price appreciation

The fact that CoC supported RP despite allegations could set a positive precedent for similar cases where process adherence is questioned

Both filings show extended CIRP periods—Omkar with a shareholder meeting in July (post-order) and Dhruv with a pending extension application—reflecting systemic delays in IBC resolution framework.

In Dhruv Wellness, only 1 out of 3 resolution plans remained after two withdrawals, indicating low bidder interest. This is a common pattern in small-to-mid cap CIRP cases where asset quality is distressed.

Dhruv’s CoC meeting prepone request and the resolution plan approval with near-unanimous voting share (98.55%) shows creditors are increasingly assertive in driving timelines—a positive structural theme.

Prafull Chedda’s allegation that IBC rules were violated, though dismissed by CoC, adds to a growing list of procedural challenges in NCLT cases—heightens execution risk for resolution plans.

Neither filing contained any forward-looking statements, earnings guidance, or growth targets—a stark contrast to operational companies, typical of CIRP entities where business continuity is uncertain.

Outcome on July 27, 2026—vote on restructuring proposals; watch for any revival scheme or potential liquidation order [July 27]

Pending NCLT order on extension—crucial for plan implementation timeline and creditor recovery [Date unknown—monitor NCLT listing]

Monitor approval by NCLT and subsequent compliance—may trigger re-rating if plan is executed and company emerges from CIRP [Ongoing]

Any appeal against the CoC decision could delay the plan further—watch for NCLAT filings [Next 30 days]

Public notices in Financial Express—watch for any shareholder requisitions or objections that could alter the meeting agenda [June 26–July 27]

The preponement request from a financial creditor may indicate tension—watch for any resignation of RP or creditor disputes [Ongoing]

Both cases are before Ahmedabad NCLT—any broader policy change or fast-track guidelines for small CIRPs could impact timelines